IBM Wants Your Help to Fight Human Bacteria

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

Teva Must Clear Three Big Hurdles to Reclaim Its Perch

Mylan Can Focus on New Generics After EpiPen Medicaid Settlement

Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain

Valeant CEO Joe Papa Has Been Able to Pay Down Debt, Jim Cramer Explains

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

Closing Bell: Teva Tumbles and Trump Disbands CEO Councils